Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Biotechnology Sector
(CIX:
MSECTOR515
)
1,910.06
-28.64 (-1.48%)
Streaming Delayed Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Sector
Overview
Sub-Sectors
Sub-Sector Map
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Open
1932.99
Prev. Close
1938.70
Today's Range
1896.18 - 1961.60
52wk Range
1358.63 - 2058.41
Components
View All
Value
% Change
Gilead Sciences, Inc.
55.74
-0.99%
Amgen, Inc.
102.18
-3.27%
Biogen Idec, Inc.
225.18
-0.74%
Regeneron Pharmaceuticals, Inc.
263.64
-1.25%
Life Technologies Corporation
73.57
+0.04%
Illumina, Inc.
73.08
+1.50%
BioMarin Pharmaceuticals, Inc.
62.43
-2.47%
Onyx Pharmaceuticals, Inc.
94.34
-1.37%
Qiagen NV
18.51
-0.75%
Seattle Genetics Inc /wa
35.75
-2.59%
Top News
More News
Lightning Round: CarMax, Asbury Automotive & More
May 20, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Read More
from
CNBC.com News
Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer.
Read More
from
CNBC.com News
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap.
Read More
from
Reuters: Company News
More News
More News
Investors Lock In Profits
May 20, 2013
After setting new records last week, the markets closed modestly lower with the Dow losing 19 points to 15,335 on profit taking. Nasdaq slipped 2 points to 3496.
Read More
from
MarketMinute.com Market Updates
Repligen Has Returned 71.8% Since SmarTrend Recommendation (RGEN)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Streetinsider.com After-Hours Movers 05/20: (SDBT) (TIVO) (REN) Higher; (HGG) (CIMT) (CCL) Lower (more...)
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356189 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356010 for the full story.
Read More
from
StreetInsider.com News Articles
Dividend Highlights/Lowlights for May 20
May 20, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Agnico-Eagle Mines (AEM) – up 6% Apple Inc. (AAPL) – up 3% AllianceBernstein...
Read More
from
Dividend Daily
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here